According to Mersana Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.18 B. In 2022 the company made an earning of -$0.21 B a decrease over its 2021 earnings that were of -$0.18 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.18 B | -15.94% |
2022 | -$0.21 B | 20.08% |
2021 | -$0.18 B | 93.16% |
2020 | -$88.05 M | 212.12% |
2019 | -$28.21 M | -56.1% |
2018 | -$64.26 M | 66.02% |
2017 | -$38.71 M | 182.53% |
2016 | -$13.7 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -35.47% | ๐บ๐ธ USA |